The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis.

Martina VeithJulia TüffersErika PeychevAndreas KlemmerViktor KotkeSabina JanciauskieneSusanne WilhelmRobert BalsAndreas Rembert KoczullaClaus Franz VogelmeierTimm Greulich

Published in: International journal of chronic obstructive pulmonary disease (2020)

COPD/emphysema and bronchiectasis, but not asthma patients, exhibit higher frequency of AATD genotypes. Our data suggest that AATD testing should be offered to patients with COPD/emphysema and bronchiectasis.

Keyphrases

lung function
cystic fibrosis
chronic obstructive pulmonary disease
end stage renal disease
air pollution
chronic kidney disease
newly diagnosed
ejection fraction
prognostic factors
electronic health record
patient reported outcomes
patient reported
allergic rhinitis